NL-OMON34982
Completed
Not Applicable
Clinical Effectiveness and Feasibility of Platelet Rich Plasma Injection in Patients with Chronic Patellar Tendinopathy - TOPPRIK
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Jumper's Knee
- Sponsor
- niversitair Medisch Centrum Groningen
- Enrollment
- 20
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •History of knee pain in the proximal section of the patellar tendon or its patellar insertion (pointed out in a anatomical drawing of the knee) in connection with training and competition
- •Symptoms for over twelve months (current symptoms for at least three months)
- •Age 18\-40 years old
- •Palpation tenderness to the corresponding painful area
- •VISA score \< 80
- •Ultrasound characteristics showing hypoechoic zones in the corresponding area
- •Recalcitrant to conservative treatment (at least eccentric training)
Exclusion Criteria
- •acute knee or patellar tendon injuries
- •chronic joint diseases
- •signs or symptoms of other coexisting knee pathology
- •pregnancy
- •Bleeding disorders and haematological disaeses
- •Malignancy
- •knee surgery
- •injection of any kind in the patellar tendon in the last preceding three months
- •use of NSAID\*S in the last 5 days before or first 6 weeks after injection or daily use of drugs with a putative effect on patellar tendinopathy in the last year (e.g. non\-steroid anti\-inflammatory drugs, fluorchinolones)
- •actual use of anticoagulants
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
orfolk Platelet And Stroke Study (PASS)StrokeCirculatory SystemISRCTN09053426orfolk and Norwich University Hospital NHS Foundation Trust (UK)80
Completed
Phase 3
Investigating the efficacy and safety of platelet rich plasma in treating hair loss of patients with lichen planopilarisIRCT20221018056229N1Iran University of Medical Sciences22
Completed
Not Applicable
Evaluation of the safety and efficacy of platelet rich plasma in treatment of patients with chronic telogen effluviumSkin and Connective Tissue DiseasesPACTR202006539654415Faculty of Medicine Sohag University30
Recruiting
Phase 2
Investigating the effectiveness of using platelet gel obtained from allogeneic umbilical cord blood in the treatment of foot ulcers in patients with diabetesIRCT20210422051040N1Shahid Beheshti University of Medical Sciences20
Completed
Not Applicable
To test the use of platelet rich plasma in melasmaCTRI/2018/06/014584Department of Dermatology40